Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy
NCT07126197
Cardiovascular Diseases, Diabetes Complications
Taipei, Taiwan
View Trial DetailsNCT Number: NCT06773793
The main objective of this observational study is to evaluate the diagnostic value of multimodal ultrasound for diabetic peripheral neuropathy (DPN). The questions it aims to address are: (1) To compare the differences in various parameters between the DPN group, non-DPN group, and healthy control group; (2) To explore the diagnostic efficacy of each parameter for DPN and establish a combined model.
Interested in participating?
Request Info18 year–75 year
All sexes
Observational
Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Individuals aged 18 to 75 years without diabetes -
Exclusion criteria
Individuals without peripheral neuropathy.
-
Time frame: from 2024-4 to 2029-4
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07126197
Cardiovascular Diseases, Diabetes Complications
Taipei, Taiwan
View Trial DetailsNCT06880484
Agnosia, Diabetes Complications
Talas, Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07708233
Diabetic Peripheral Neuropathy (DPN)
Pathumthani, Bangkok, Thailand
View Trial DetailsNCT07595887
Diabetes Mellitus, Diabetes Mellitus, Type 2
Taiyuan, Shanxi, China
View Trial Details